Perspective Therapeutics, Inc. Stock
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 USD | -0.59% | +18.18% | +320.40% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 998M |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | -56M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-18.9
x | P/E ratio 2025 * |
-14.8
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.6% |
Latest transcript on Perspective Therapeutics, Inc.
1 day | +11.11% | ||
1 week | +16.44% | ||
Current month | +42.86% | ||
1 month | +33.86% | ||
3 months | +258.65% | ||
6 months | +502.84% | ||
Current year | +322.89% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 51 | 23-02-02 |
Mark Austin
DFI | Director of Finance/CFO | 37 | - |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 23-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 23-05-31 |
Lori Woods
CHM | Chairman | 62 | 23-02-02 |
Director/Board Member | 58 | 23-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.69 | -0.59% | 6 371 662 |
24-04-23 | 1.7 | +11.11% | 6,552,861 |
24-04-22 | 1.53 | +2.00% | 5,517,631 |
24-04-19 | 1.5 | +2.04% | 3,206,303 |
24-04-18 | 1.47 | +2.80% | 5,058,358 |
Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+322.89% | 998M | |
-2.25% | 187B | |
-1.32% | 108B | |
-3.92% | 67.71B | |
+7.99% | 53.07B | |
+15.74% | 47.36B | |
+6.01% | 39.73B | |
+10.81% | 28.56B | |
+2.34% | 26.55B | |
+15.97% | 25.13B |
- Stock Market
- Equities
- CATX Stock